Log in to search using one of your social media accounts:


Dear Lupus, I want me back

My name is Lauren Johnson. I'm an associate producer at CNN, and I have systemic lupus erythematosus.
Source: CNN.com - Health - Category: Consumer Health News Source Type: news

Related Links:

This study aimed to perform a systematic review and meta-analysis on the association between vitamin D levels and AA.
Source: Journal of the American Academy of Dermatology - Category: Dermatology Authors: Tags: Research letter Source Type: research
Source: Clinical Rheumatology - Category: Rheumatology Source Type: research
Satish Maharaj, Simone Chang, Karan Seegobin, Christian AbrahimJournal of Global Infectious Diseases 2017 9(4):162-163
Source: Journal of Global Infectious Diseases - Category: Infectious Diseases Authors: Source Type: research
Ze Xiu Xiao, Xu Zheng, Li Hu, Julie Wang, Nancy Olsen, Song Guo Zheng
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
Discussion Sjögren Syndrome (SS) is named for Swedish ophthalmologist Henrik Sjögren who published a case series in 1933 describing patients with dry eyes and arthritis. SS is a “chronic autoimmune inflammatory exocrinopathy” that is characterized by lymphocytic infiltration of the lacrimal and salivary glands and has various degrees of systematic involvement. Keratoconjunctivitis sicca and xerostomia are the main clinical symptoms. Sicca is a Latin word meaning dry. Dryness of the eyes and mouth without evidence of autoimmune disease is called Sicca syndrome or Sicca complex. SS can be primary or se...
Source: PediatricEducation.org - Category: Pediatrics Authors: Tags: Uncategorized Source Type: news
Source: British Journal of Dermatology - Category: Dermatology Authors: Tags: Critically Appraised Topic Source Type: research
SummaryBased on their immunomodulatory properties, high‐dose intravenous immunoglobulins (IVIGs) are successfully used in the treatment of various dermatological autoimmune diseases, in particular pemphigus vulgaris and dermatomyositis. In autoimmune bullous diseases, IVIGs can be used in an adjuvant setting (second‐ or third‐line therapy) once combined immunosuppressive regimens have failed. In dermatomyositis, IVIGs may already be employed as an adjuvant second‐line therapy after failure of corticosteroid monotherapy. In scleromyxedema, IVIGs may be considered as first‐line treatment, given the lack of effectiv...
Source: JDDG - Category: Dermatology Authors: Tags: CME Article Source Type: research
Zusammenfassung Hochdosierte intravenöse Immunglobuline (IVIg) werden aufgrund ihrer immunmodulatorischen Eigenschaften erfolgreich zur Behandlung dermatologischer Autoimmunkrankheiten eingesetzt. Hierbei stellen der Pemphigus vulgaris und die Dermatomyositis klassische Indikationen dar. Bei den bullösen Autoimmundermatosen kann der adjuvante Einsatz von IVIg als Zweit‐ oder Drittlinientherapie nach Versagen einer kombinierten immunsuppressiven Therapie erfolgen, während in der Behandlung der Dermatomyositis IVIg bereits als adjuvante Zweitlinientherapie nach Versagen einer Steroidmonotherapie eingesetzt w...
Source: JDDG - Category: Dermatology Authors: Tags: CME ‐Artikel Source Type: research
Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder characterized by inflammation of organs systems in the body. Active SLE can put a patient at risk for life-threatening complications such as lupus nephritis (LN), an inflammation of the kidneys that can cause permanent, irreversible organ damage. LN can mimic other illnesses, and medical management may be challenging. The purpose of this article is to aid nurse practitioners in identifying and managing LN as a complication of SLE to provide safe and quality care to patients.
Source: The Journal for Nurse Practitioners - Category: Nursing Authors: Tags: Continuing Education Source Type: research
AbstractSystemic lupus erythematosus (SLE) is a significant risk factor for cardiovascular disease. The relationship between SLE and perioperative cardiovascular risks following non-cardiac surgery is uncertain. We investigated associations between a diagnosis of SLE and outcomes following major non-cardiac surgery in a large national database from the United States. Patients age  ≥ 18 years requiring major non-cardiac surgery were identified from Healthcare Cost and Utilization Project’s National Inpatient Sample data from 2004 to 2014. Systemic lupus erythematosus and perioperative major adver...
Source: Journal of Thrombosis and Thrombolysis - Category: Hematology Source Type: research
More News: Health | Lupus